Sector consensus Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 02:10:10 2026-09-25 EDT			5-day change	1st Jan Change
8.020 ^AUD	-2.91%		-4.18%	-35.63%

09-09	Clinuvel Pharmaceuticals Ltd Completes Development Of Zerokin Single-Use Administration Device For Controlled-Release Formulations	CI
09-07	Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
CLINUVEL PHARMACEUTICALS LIMITED			17.36	+116.44%	6
MODERNA, INC.			119.56	-39.89%	18
REGENERON PHARMACEUTICALS, INC.			850.88	+7.97%	26
CSL LIMITED			126.28	+1.62%	17
UCB			285	+32.93%	19
SAMSUNG BIOLOGICS CO.,LTD.			1,972,615.38	+44.41%	26
BIOGEN INC.			238.18	+4.65%	31
INCYTE CORPORATION			127.74	+3.11%	23
INNOVENT BIOLOGICS, INC.			110.48	+29.52%	29
SWEDISH ORPHAN BIOVITRUM AB			500.92	+14.84%	12
ALTEOGEN INC.			405,512.82	+62.21%	6
BRIDGEBIO PHARMA, INC.			109.1	+66.38%	21
BIOMARIN PHARMACEUTICAL INC.			91.62	+52.03%	26
TWIST BIOSCIENCE CORPORATION			109.58	-40.06%	12
KRYSTAL BIOTECH, INC.			392.11	+13.39%	9
AXSOME THERAPEUTICS, INC.			285.22	+46.2%	22
GRIFOLS, S.A.			14.76	+53.83%	12
GAN & LEE PHARMACEUTICALS.			83	+13.02%	2
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC			98	+30.53%	8
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	-	60.94	+55.42%	1
Average			119,087.45	+28.43%	16
Weighted average by Cap.			194,024.39	+11.22%	21